© Reuters. FILE PHOTO: A picture illustration shows a $100 banknote laying $1 banknotes By Joshua Franklin and Kate Duguid NEW YORK (Reuters) – Whatever nickname ultimately gets attached to the now-ending Twenty-tens, on Wall Street and across Corporate America it arguably should be tagged as the “Decade of Debt.”Read More →

Acadia Pharmaceuticals (ACAD) announced that it had achieved positive results from a pivotal study known as ADVANCE using its drug pimavanserin to treat negative symptoms of schizophrenia. The initial market reaction was mixed, based on narrowly achieving statistical significance. However, an opportunity exists to move forward. On top of that,Read More →

It’s no longer just me using terms like “Armageddon, crisis, devastating, chaos, Great Depression;” it’s leaders of the world’s most august and conservative central banks. The big banking squeeze that began in September never went away. In fact, repo auctions last week looked worse than ever, in spite of theRead More →